Cargando…
Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-associated death worldwide, characterized by a high invasiveness and resistance to normal anticancer treatments. The need to develop new therapeutic agents for HCC is urgent. Here, we developed a bioinformatics method to identi...
Autores principales: | Wang, Jiye, Li, Mi, Wang, Yun, Liu, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788366/ https://www.ncbi.nlm.nih.gov/pubmed/27022281 http://dx.doi.org/10.2147/OTT.S97211 |
Ejemplares similares
-
Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015) -
Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020) -
Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
por: Shi, Xinrui, et al.
Publicado: (2016) -
ce‐Subpathway: Identification of ceRNA‐mediated subpathways via joint power of ceRNAs and pathway topologies
por: Feng, Chenchen, et al.
Publicado: (2018) -
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)